Insider · CIK 0001302605
Tina Susan Nova
director
Files at AZTA (Azenta, Inc.), XGN (EXAGEN INC.), AUPH (Aurinia Pharmaceuticals Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +13,500 | $0.00 | $0 | 13,500 | Jun 12, 2025 |
| May 16, 2025 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Director Stock Option (right to buy)derivative | +63,724 | $0.00 | $0 | 63,724 | May 16, 2025 |
| Feb 7, 2025 | AZTA Azenta, Inc. | AGrant or award Common | +4,040 | $52.32 | $211k | 10,109 | Feb 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.